News

Photo: Alamy Dr. Mehmet Oz, the Trump administration’s administrator for the Centers for Medicare and Medicaid Services, supported the president’s plan to lower drug prices for Americans in a new ...
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia ...
Despite early success, however, Novo Nordisk has fallen behind in the GLP-1RA race, overtaken by Eli Lilly and its GLP-1RA ...
Letters published May 13-19, 2025, deal with research funding, drug prices and what God says about diversity and dignity.
President Donald Trump's order to for pharmaceutical companies to cut drug prices received mixed reactions, with some members ...
Hi, it’s Amber in Hong Kong. Across the strait in Taiwan, breakthrough Alzheimer’s drugs are finally becoming available but ...
Despite recent stock corrections, Piramal Pharma has shown remarkable resilience, tripling investor wealth since 2023-24.
Experts said the president's executive order could work in lowering costs, but it won't make for an immediate fix.
A federal district court ruled in favor of the Health Resources and Services Administration, but raised questions about ...
The order is expected to impact innovator companies, which may spend less on research in an effort to cut costs, analysts ...
A drug dealer who was caught swallowing heroin and crack cocaine in Betfred, a dad who turned violent on the school run and a thug who ripped his girlfriend's hair out outside Lime Street Station were ...
It is not surprising that President Trump issued a May 12, 2025 executive order, “Delivering Most-Favored-Nation Prescription ...